Prothrombotic effects and clinical implications of third-generation oral contraceptives use

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 1, 2002, Pages 69-72

  Lippi, G ^a   Manzato, F ^a   Brocco, G ^a   Franchini, M ^b   Guidi, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Haemostasis; Oral contraceptives; Protein S; Venous thromboembolism

Indexed keywords

ANTITHROMBIN; DESOGESTREL; ETHINYLESTRADIOL; GESTAGEN; GESTODENE; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM;

ADULT; ANTITHROMBIN III; BLOOD COAGULATION TESTS; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; DRUG EVALUATION; ETHINYL ESTRADIOL; FEMALE; HEMOSTASIS; HUMANS; NORPREGNENES; PROTEIN C; PROTEIN S; REFERENCE VALUES; THROMBOPHILIA;

EID: 0036240148     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200201000-00011     Document Type: Article

References (10)

1. Forty years of combined oral contraception: The evolution of a revolution
2. Third generation oral contraceptives and risk of venous thrombosis: Meta-analysis
3. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: Cohort and case-control analysis
4. Oral contraceptives, thrombosis and haemostasis
5. Biological coagulation findings in third-generation oral contraceptives
6. APC resistance, oral contraceptive therapy and deep vein thrombosis: Settled and unsettled problems
7. Epidemiology of oral contraceptives and cardiovascular disease
8. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways
9. Thrombophilia as a multigenic disease
10. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives